Vizgen

Vizgen, Inc. is a privately held biotechnology company dedicated to developing next-generation spatially resolved single-cell transcriptomics technologies and toolboxes. The company's patented MERFISH technology enables large-scale, multi-genomic scale nucleic acid imaging with high precision and high detection efficiency at subcellular resolution. The high throughput, resolution, and lower per-cell cost enabled by this technology will facilitate broad tissue-scale basic research and development, and will contribute to the discovery and mapping of cell types and states across a range of tissues and organisms.